Literature DB >> 9817722

Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease.

A Noguera1, X Busquets, J Sauleda, J M Villaverde, W MacNee, A G Agustí.   

Abstract

We investigated the expression of adhesion molecules in circulating neutrophils (lymphocyte function-associated antigen-1 [LFA-1], Mac-1, and L-selectin) and endothelial cells (soluble intercellular adhesion molecule-1[sICAM-1]) in 23 patients with stable chronic obstructive pulmonary disease (COPD), 18 subjects with exacerbated COPD, and 23 healthy volunteers. Also, in these circulating neutrophils, we assessed the expression of two G protein subunits (Galphas and Galphai1/2). Compared with control subjects, patients with stable COPD showed increased expression of Mac-1 (p < 0.001) and lower levels of sICAM-1 (p = 0.002); LFA-1 and L-selectin expression was similar in patients and control subjects. During exacerbations, compared with stable patients, the expression of Mac-1 and LFA-1 was reduced (p < 0.001). Finally, the expression of Galphas (but not Galphai1/2) was also reduced (p < 0.001) in circulating neutrophils of patients with COPD, irrespective of the clinical condition of the patient. These results indicate that in patients with COPD: (1) the expression of some neutrophil adhesion molecules (Mac-1) is abnormal, and that this pattern changes during exacerbations; (2) there may be a form of endothelial dysfunction, as suggested by the low sICAM-1 levels; (3) the expression of G protein subunit (Galphas) in circulating neutrophils is downregulated, irrespective of their clinical conditions. Overall, these results indicate the presence of significant systemic abnormalities in COPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817722     DOI: 10.1164/ajrccm.158.5.9712092

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  Flow cytometry in the exploration of the physiopathology of occupational lung disease.

Authors:  A D Curran
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

2.  Enhanced neutrophil response in chronic obstructive pulmonary disease.

Authors:  A Noguera; S Batle; C Miralles; J Iglesias; X Busquets; W MacNee; A G Agustí
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

3.  Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.

Authors:  Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Nadia Boutaoui; Helene Bacherman; Barbara Klanderman; Stephen Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L DeMeo
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

Review 4.  NADPH oxidases: an overview from structure to innate immunity-associated pathologies.

Authors:  Arvind Panday; Malaya K Sahoo; Diana Osorio; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2014-09-29       Impact factor: 11.530

5.  Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation.

Authors:  David H McMillan; Carolyn J Baglole; Thomas H Thatcher; Sanjay Maggirwar; Patricia J Sime; Richard P Phipps
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

6.  C-reactive protein in patients with COPD, control smokers and non-smokers.

Authors:  V M Pinto-Plata; H Müllerova; J F Toso; M Feudjo-Tepie; J B Soriano; R S Vessey; B R Celli
Journal:  Thorax       Date:  2005-09-02       Impact factor: 9.139

7.  Neutrophilic inflammatory response and oxidative stress in premenopausal women chronically exposed to indoor air pollution from biomass burning.

Authors:  Anirban Banerjee; Nandan Kumar Mondal; Debangshu Das; Manas Ranjan Ray
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 8.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

Review 9.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Biological targets for therapeutic interventions in COPD: clinical potential.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Luca Gallelli; Teresa Renda; Mario Caputi; Rosario Maselli; Serafino A Marsico
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.